Results 211 to 220 of about 125,907 (238)
Some of the next articles are maybe not open access.
In Vivo Bacteriophage Biodistribution
2017At the dawn of the renaissance of bacteriophage therapy, the full acceptation of bacteriophages as anti-bacterial agents requires the determination of their basic pharmacokinetic parameters. Such data, known for all conventional drugs used in human and veterinary medicine, allow optimizing dose regimens, efficacy, and help to limit toxicity.
Dufour, Nicolas +2 more
openaire +4 more sources
Bioconjugation and biodistribution
2002The term “bioconjugation ” usually defines the specific covalent linking between two biomolecules, in order to obtain a novel molecular entity with peculiar physicochemi-cal and biological properties (1). In medicine, bioconjugation is mainly exploited to impart biological specificity to drugs or diagnostics.
VERONESE F.M., CALICETI, PAOLO
openaire +3 more sources
Liposome Biodistribution via Europium Complexes
2009Vector biodistribution is a requirement prior pharmaceutical development. Radioactive tracers allow the most sensitive and quantitative assessment of biodistribution, and conventional fluorophores are widely used in academic laboratories. We propose here to use europium complexes as a label for nanoparticles or biotherapeutics taking liposomes as ...
Nathalie, Mignet, Daniel, Scherman
openaire +4 more sources
Iatrogenic alterations in radionuclide biodistributions
Seminars in Nuclear Medicine, 1979The biodistribution of radiotracers used in diagnostic imaging is grossly and recognizably altered by a wide variety of drugs and other treatment modalities, such as surgery and radiotherapy. Knowledge of such altered biodistribution is important both in making diagnostic inferences from scans and in dosimetric considerations.
B C, Lentle +3 more
openaire +2 more sources
Antithrombin III: Biodistribution in Healthy Volunteers
Thrombosis and Haemostasis, 1987SummaryFive healthy volunteers were injected intravenously with 73-90 uCi purified human 131I-Antithrombin III (AT III), specific biological activity 5.6 U/mg. The tracer data were analysed using a three compartment model. The plasma radioactivity half life was 66.2 ± 1.2 (sem) h, the fractional catabolic rate constant of the plasma pool was 0.025 ± 0 ...
Knot, E. A. +4 more
openaire +3 more sources
Scintigraphic visualization of intrathecal liposome biodistribution
Acta Anaesthesiologica Scandinavica, 1997Background: Liposomes containing local anaesthetics have been administered intrathecally and in the epidural space. Poor attention has been given to the pharmacokinetics of liposomes as drug carriers. Therefore, we observed the biodistribution of liposomes after intrathecal injection in rats by scintigraphic imaging during 24 h.Methods: We administered
Umbrain, V +9 more
openaire +4 more sources
Biodegradation, biodistribution and toxicity of chitosan
Advanced Drug Delivery Reviews, 2010Chitosan is a natural polysaccharide that has attracted significant scientific interest during the last two decades. It is a potentially biologically compatible material that is chemically versatile (-NH2 groups and various M(w)). These two basic properties have been used by drug delivery and tissue engineering scientists to create a plethora of ...
Kean, T., Thanou, M.
openaire +3 more sources
Biodistribution of Radiolabeled Ethanol in Rodents
Drug Metabolism and Disposition, 2008The biodistribution of [1-(14)C]ethanol in rodents was examined to determine sites of concentration of ethanol or its metabolites that may contribute to its toxicological and pharmacokinetic characteristics. After i.v. administration of [1-(14)C]ethanol in mice, radioactivity showed a widespread distribution among body organs.
Andrew N, Gifford +2 more
openaire +2 more sources
Biodistribution of radiolabeled lymphocytes.
Radiology, 1985Factors that might affect the biodistribution and clinical utility of radiolabeled lymphocytes were evaluated in experimental animals. Indium-111 (In-111) labeled lymphocytes (10(7)-10(9) syngeneic or allogeneic cells; 1-10 microCi [.037-.37 MBq]/10(8) cells) obtained from peripheral blood, lymph node, or spleen were found in significant amounts in the
R A, Fawwaz +6 more
openaire +2 more sources
Biodistribution of covalent antithrombin-heparin complexes
Thrombosis and Haemostasis, 2006SummaryWe have developed a covalent antithrombin-heparin (ATH) complex with advantages compared to non-covalent antithrombin: heparin (AT:H) mixtures. In addition to increased activity, ATH has a longer intravenous half-life that is partly due to reduced plasma protein binding.
Paul A, Chindemi +4 more
openaire +2 more sources

